StockData
Mesoblast Ltd logo

Mesoblast Ltd (MESO) stock

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Mesoblast gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2026 it was 86.1%, against 70.2% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 202686.1%+16.0
FY2025Jun 30, 202570.2%−29.8
FY2024Jun 30, 2024100.0%+0.0
FY2023Jun 30, 2023100.0%–

More Mesoblast figures

See a number that looks wrong?